Genotypic testing is an important laboratory procedure used to identify HIV mutations that may cause resistance to certain antiretroviral medicines. Before starting HIV treatment, healthcare professionals may recommend this test to understand the virus's genetic characteristics and select appropriate medications. It helps identify resistance patterns, supports treatment planning, and provides information about which medicines may be less effective.
Before starting HIV treatment, healthcare professionals may recommend resistance testing to understand whether the virus has mutations that could affect medication effectiveness. This information is particularly important because individuals can acquire HIV strains that already contain drug-resistant mutations. In other situations, resistance may develop when treatment does not adequately suppress viral replication.
The test generally examines specific regions of HIV genetic material associated with resistance to different medication classes. The results help healthcare professionals understand which medicines are likely to remain effective.
Important aspects of genotypic testing include:
Resistance identification: Detects genetic mutations associated with resistance to specific HIV medicines.
Treatment selection: Helps healthcare professionals choose an appropriate antiretroviral therapy regimen.
Baseline assessment: Provides information about existing resistance before treatment begins.
Medication effectiveness: Helps identify medicines that may have reduced activity against the detected HIV strain.
Treatment planning: Supports decisions about initial therapy and future medication options.
Genotypic testing is generally recommended for people newly diagnosed with HIV before beginning antiretroviral therapy. However, treatment should not be unnecessarily delayed while waiting for test results when immediate treatment is clinically appropriate. Healthcare professionals can determine the most suitable approach based on individual circumstances.
Genotypic testing usually involves collecting a blood sample to measure the amount of HIV genetic material and examine specific viral genes. The laboratory analyzes these genes to identify mutations associated with resistance to antiretroviral medications.
The test commonly examines the protease and reverse transcriptase genes. Depending on the treatment history and clinical circumstances, integrase gene testing may also be performed. These genetic regions are important because they are associated with the activity of different HIV medication classes.
The general testing process involves several stages.
Blood sample collection: A healthcare professional collects a blood sample for laboratory analysis.
Viral genetic material analysis: The laboratory extracts and examines HIV RNA from the sample.
Gene sequencing: Specific regions of the viral genetic material are analyzed to identify mutations.
Resistance assessment: Detected mutations are compared with established HIV drug resistance information.
Result interpretation: Healthcare professionals review the findings to determine which antiretroviral medicines may be effective.
The results generally identify whether the virus contains mutations associated with resistance to particular medications. Some mutations cause high-level resistance, while others may produce intermediate or low-level resistance. Certain mutations can also affect how well multiple medicines within the same drug class work.
Healthcare professionals interpret these findings alongside the patient's medical history, viral load, CD4 cell count, previous medication exposure, and other relevant clinical information.
It is important to understand that a genotypic resistance test does not directly measure how well a medicine will work in an individual. Instead, it identifies genetic changes associated with reduced medication sensitivity. Additionally, some resistant viral populations may not be detected if they represent only a small proportion of the virus present in the blood.
The results therefore provide valuable information for selecting an appropriate treatment regimen, monitoring HIV management, and understanding potential resistance concerns.